Reaction
Non-Infectious Endophthalmitis reporting signals
As of the last recalculation, Non-Infectious Endophthalmitis appears in 840 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 814.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 462 | 814.2 | 826.5 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 121 | 149.4 | 150.2 |
| Triamcinolone Acetonide | 125 | 117.6 | 118.1 |
| Faricimab | 32 | 101.7 | 102.1 |
| Ranibizumab | 75 | 76.8 | 77.0 |
| Prednisolone Acetate | 11 | 26.7 | 26.7 |
| Moxifloxacin Hydrochloride | 21 | 26.3 | 26.3 |
| Bevacizumab | 67 | 14.5 | 14.5 |
| Timolol | 7 | 14.5 | 14.5 |